The U.S. Centers for Disease Control and Prevention (CDC) is refusing to release the latest data related to heart failure recorded in patients who had recently received Covid vaccinations.
The federal health agency has not updated information on reported cases of myocarditis and pericarditis following COVID-19 vaccination.
Myocarditis and pericarditis are conditions related to inflation in the heart.
While pericarditis can be uncomfortable, myocarditis can be potentially fatal.
Myocarditis is inflammation of the heart muscle (myocardium) that reduces the heart’s ability to pump blood.
It can cause blood clots, strokes, or heart failure, and possibly lead to death.
Both myocarditis and pericarditis are known side effects of Covid mRNA shots.
The CDC has regularly conveyed the number of post-vaccination myocarditis and pericarditis cases to the Vaccine Adverse Event Reporting System (VAERS).
The CDC helps to manage VAERS, which allows medical practitioners to report vaccine side effects they record in patients.
VAERS data is used by the CDC to consult with the agency’s advisers on updates to the vaccines.
However, during a meeting on September 12, the CDC failed to give any updates on VAERS data.
When asked for the information, an agency spokesman pointed to a CDC study that covers data only through October 23, 2022.
That study identified nine reports of myocarditis or pericarditis following vaccination with one of the bivalent COVID-19 vaccines, which were introduced in September 2022.
Seven of the reports were verified by medical review.
Asked for more current data, the spokesman acknowledged the agency has it but admitted that the agency is refusing to make it public.
The CDC declined to reveal why the meeting was not an appropriate time to release the date.
Many have raised concerns about the lack of transparency as Democrat President Joe Biden’s administration rolls out new “booster” shots for public use.
“The CDC has acknowledged that heart inflammation is a complication of mRNA COVID-19 shots and, yet, the only published data released by CDC officials about that complication is a seven-week study that ended on Oct. 23, 2022,” responded Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center.
“Where is more specific myocarditis/pericarditis data related to bivalent Covid shots for the past 10 months?”
The mRNA shots are made by pharmaceutical giants Pfizer and Moderna.
Novavax’s updated shot, which uses different technology, has not yet been authorized by the U.S. Food and Drug Administration (FDA), unlike the mRNA shots.
Kim Witczak, a drug safety advocate who runs the nonprofit Woodymatters, accused the Biden admin of an “evil” cover-up as schools push to mandate the shots.
“I am tired of the CDC and FDA deciding what information the public needs and doesn’t need,” Witczak said.
“This is precisely the information that parents need to have especially when there are still schools and activities mandating these shots.
“This is evil playing out right before our eyes.
“The CDC’s response of ‘when appropriate, the updated safety data will be published’ is unacceptable and they wonder why there is vaccine hesitancy and lack of trust in public health officials.”
During the recent meeting, CDC officials and their partners presented data on the bivalent shots to the Advisory Committee on Immunization Practices.
The advisory panel was tasked with considering which groups should be recommended to get one of the new Covid vaccines.
The injections were cleared for public use by regulators with scant clinical trial data.
Dr. Nicola Klein, a Kaiser Permanente doctor who works closely with the CDC, gave a presentation (pdf) on Covid vaccine safety.
She presented data from the Vaccine Safety Datalink (VSD), a monitoring system that covers a much smaller population than VAERS.
Dr. Klein said that two cases of myocarditis after bivalent vaccination were detected in the Vaccine Safety Datalink (VSD) through March 11.
Klein claimed that there weren’t enough cases to trigger a safety signal among adults but refused to say why more current data wasn’t not presented.
The data presented was widely cited by doctors quoted in news outlets.
Dr. Andrew Pavia told a press briefing that there did not appear to be a “detectable risk” of the bivalent shots causing myocarditis, despite having not reviewed the latest data.
When presenting to the panel, CDC official Megan Wallace said, “There are limited data to inform the myocarditis risk following an updated mRNA dose.”
She did not mention the cases reported to VAERS but alleged the benefits of the vaccines outweigh the risks, even for young, healthy males.
Wallace did not mention why she felt young healthy people were at “risk” from a virus with only mild symptoms.
The Vaccine Safety Datalink, she acknowledged, did have a “relatively lower sample size” of recipients.
Panel members appeared satisfied, despite the lack of data.
After the presentation, Dr. Oliver Brooks said the public should “Feel good about the fact that in the bivalent we saw no signal from myocarditis.”
“Very important,” added Brooks, the chief medical officer at Watts Healthcare Corporation.
Dr. Pablo Sanchez, the only member to advise against a widespread recommendation, said the risk of myocarditis was a reason.
“I think we really need to level with our patients and say what is known and unknown, rather than make a complete recommendation, especially for some groups that there are limited data,” he said.
Big Pharma companies are shielded from any backlash, however, as the labels for the new vaccines say they can cause myocarditis.
“Postmarketing data with authorized or approved mRNA COVID-19 vaccines demonstrate increased risks of myocarditis and pericarditis, particularly within the first week following vaccination,” the labels state.
While some people have recovered, many others have not.
The labels also say, “Information is not yet available about potential long-term sequelae.”